Volume 58, Issue 1 p. 2.16.1-2.16.19
UNIT

Use of Channelrhodopsin for Activation of CNS Neurons

Jonathan P. Britt

Jonathan P. Britt

Cellular Neurobiology Research Branch, National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, Baltimore, Maryland

Search for more papers by this author
Ross A. McDevitt

Ross A. McDevitt

Cellular Neurobiology Research Branch, National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, Baltimore, Maryland

Search for more papers by this author
Antonello Bonci

Antonello Bonci

Cellular Neurobiology Research Branch, National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, Baltimore, Maryland

Search for more papers by this author
First published: 01 January 2012
Citations: 14

Abstract

Optogenetics—the use of optically activated proteins to control cell function—allows for control of neurons with an unprecedented degree of spatial, temporal, and neurochemical precision. Three protocols are presented in this unit describing the use of channelrhodopsin-2 (ChR2), a light-activated cation channel. These protocols emphasize practical issues of working with ChR2, including guidelines for selecting a gene delivery method, light source, and method of tissue implantation, as well as steps for fabricating fiber optic patch cables and chronic implantable optical fibers. The first protocol describes the use of ChR2 in electrophysiological recordings from brain slices. The second and third involve the use of ChR2 in vivo, with light delivered through chronic fiber implants or guide cannula. Curr. Protoc. Neurosci. 58:2.16.1-2.16.19. © 2012 by John Wiley & Sons, Inc.